U.S. MARKETS FOR PERIPHERAL VASCULAR STENTS

191 Pages | 39 Exhibits | 2011 Analysis | Forecasts Through 2014

OVERVIEW:
First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2009, peripheral vascular stents were used in approximately 487,300 interventional procedures in the U.S., generating approximately $1.2 billion in corresponding product sales. Over the forecast period covered by this report, the number of peripheral vascular stenting procedures performed in the U.S. is expected to increase at a compound annual rate of 7.2%, reaching approximately 689,200 in the year 2014; during the same period, corresponding dollar sales are expected to increase at a compound annual rate of 9.9%, reaching approximately $1.9 billion in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. peripheral vascular stents market. Major topics covered by this report include a discussion of current and emerging peripheral vascular stenting technologies; a clinical overview of peripheral vascular conditions targeted by stenting (e.g., abdominal and thoracic aortic aneurysm, carotid artery stenosis, lower extremity occlusive artery disease, renal artery stenosis/refractory hypertension, and variceal bleeding/acute portal hypertension) and an analysis of endovascular aortic aneurysm repair systems, carotid artery stenting systems, lower extremity (e.g., femoropopliteal, iliac, and infrapopliteal artery) stenting systems, renal stenting systems, and transjugular intrahepatic portosystemic shunt systems.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

a. Peripheral Vascular Stenting Systems 
b. Stent Design and Materials 
c. Products 
	i. Endovascular Aortic Aneurysm Repair Systems 
	ii. Carotid Artery Stenting Systems 
	iii. Lower Extremity Stenting Systems 
	iv. Renal Stenting Systems 
	v. Transjugular Intrahepatic Portosystemic Shunt Systems 
d. Market Analysis 

Exhibit ES-1: 2009, Estimated Incidence and Prevalence of Peripheral Vascular Conditions Targeted by Stenting Techniques 
Exhibit ES-2: Peripheral Vascular Stenting, Procedure Volumes Forecast, 2009-2014 
Exhibit ES-3: Peripheral Vascular Stenting Systems, Market Forecast, 2009-2014 

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design
	1.1.1 Vascular Stents 
	1.1.2 Nonvascular Stents
	1.1.3 Stent Deployment Mechanisms 
1.2 Stent Materials 
	1.2.1 Metal Stents 
		1.2.1.1 Absorbable Magnesium Alloys 
		1.2.1.2 Cobalt Alloys 
		1.2.1.3 Nickel-Titanium Alloys 
		1.2.1.4 Stainless Steel
	1.2.2 Standard Polymeric Stents 
	1.2.3 Biodegradable Polymeric Stents 
1.3 Stent Coatings 
	1.3.1 Radiopacity Enhancement 
	1.3.2 Biocompatibility Enhancement 
	1.3.3 Active Therapeutic Enhancement 
		1.3.3.1 Drug-Eluting Stents 
			1.3.3.1.1 Antirestenotic Drug-Eluting Stents 
			1.3.3.1.2 Drug Delivery Techniques 
	1.3.4 Stent Coverings and Linings 

Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements 
Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs 
Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials 
Exhibit 1-4: Selected Polymeric Stent Materials 
Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents 
Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents 

2. CLINICAL OVERVIEW OF PERIPHERAL VASCULAR STENTS

2.1 Anatomy and Physiology of the Vascular System 
2.2 Peripheral Vascular Conditions Targeted by Stenting 
	2.2.1 Aortic Aneurysm 
		2.2.1.1 Treatment 
			2.2.1.1.1 Watchful Waiting 
			2.2.1.1.2 Surgical Intervention 
			2.2.1.1.3 Endovascular Repair of Abdominal Aortic Aneurysm 
			2.2.1.1.4 Endovascular Repair of Thoracic Aortic Aneurysm 
			2.2.1.1.5 Procedure Volumes 
	2.2.2 Carotid Artery Stenosis and Ischemic Stroke 
		2.2.2.1 Etiology of Stroke 
		2.2.2.2 Carotid Artery Stenosis and Cerebral Thrombosis 
		2.2.2.3 Treatment 
			2.2.2.3.1 Carotid Endarterectomy 
			2.2.2.3.2 Carotid Artery Stenting 
	2.2.3 Lower Extremity Arterial Occlusions 
		2.2.3.1 Treatment 
			2.2.3.1.1 Surgical Revascularization 
				2.2.3.1.1.1 Aortoiliofemoral Bypass Grafting 
				2.2.3.1.1.2 Femoropopliteal Bypass Surgery 
				2.2.3.1.1.3 Distal Tibial/Peroneal Vascular Reconstruction 
				2.2.3.1.1.4 Thrombo-endarterectomy 
			2.2.3.1.2 Interventional Treatment 
				2.2.3.1.2.1 Percutaneous Transluminal Angioplasty 
			2.2.3.1.3 Lower Extremity Stenting 
				2.2.3.1.3.1 Iliac Artery Stenting 
				2.2.3.1.3.2 Femoropopliteal Artery Stenting 
				2.2.3.1.3.3 Infrapopliteal Stenting 
				2.2.3.1.3.4 Procedure Volumes 
	2.2.4 Renal Artery Stenosis 
		2.2.4.1 Treatment 
			2.2.4.1.1 Surgical Revascularization 
			2.2.4.1.2 Renal Artery Angioplasty 
			2.2.4.1.3 Renal Artery Stenting 
				2.2.4.1.3.1 Renal Drug-Eluting Stenting 
				2.2.4.1.3.2 Procedure Volumes 
	2.2.5 Portal Hypertension and Variceal Bleeding 
		2.2.5.1 Treatment 
			2.2.5.1.1 Surgical Decompression Shunt 
			2.2.5.1.2 Transjugular Intrahepatic Portosystemic Shunt 
				2.2.5.1.2.1 Procedure Volumes 
	2.2.6 Other Applications for Peripheral Vascular Stenting 
		2.2.6.1 Subclavian Artery Stenosis Treatment 
		2.2.6.2 Venous Stenting 

Exhibit 2-1: 2009, Aortic Aneurysm, Facts and Figures 
Exhibit 2-2: Endovascular Aortic Aneurysm Repair, Procedure Volumes Forecast, 2009-2014 
Exhibit 2-3: 2009, Carotid Artery Stenosis, Facts and Figures 
Exhibit 2-4: Carotid Artery Stenting, Procedure Volumes Forecast, 2009-2014 
Exhibit 2-5: 2009, Lower Extremity Occlusive Artery Disease,  Facts and Figures 
Exhibit 2-6: Lower Extremity Primary and Adjuvant Stenting, Procedure Volumes Forecast, 2009-2014 
Exhibit 2-7: 2009, Renal Artery Stenosis, Facts And Figures 
Exhibit 2-8: Renal Artery Stenting, Procedure Volumes Forecast, 2009-2014 
Exhibit 2-9: 2009, Acute Portal Hypertension and Variceal Bleeding,  Facts and Figures 
Exhibit 2-10: Transjugular Intrahepatic Portosystemic Shunt, Procedure Volumes Forecast, 2009-2014 

3. PERIPHERAL VASCULAR STENTS MARKET

3.1 Endovascular Aortic Aneurysm Repair Systems 
	3.1.1 Products and Technology 
	3.1.2 Market Forecast 
	3.1.3 Competitive Analysis 
3.2 Carotid Artery Stenting Systems 
	3.2.1 Products and Technology 
	3.2.2 Market Forecast 
	3.2.3 Competitive Analysis 
3.3 Lower Extremity Stenting Systems 
	3.3.1 Products and Technology 
	3.3.2 Market Forecast 
	3.3.3 Competitive Analysis 
3.4 Renal Stenting Systems 
	3.4.1 Products and Technology 
	3.4.2 Market Forecast 
	3.4.3 Competitive Analysis 
3.5 Transjugular Intrahepatic Portosystemic Shunt Systems 
	3.5.1 Products and Technology 
	3.5.2 Market Forecast 
	3.5.3 Competitive Analysis 

Exhibit 3-1: Peripheral Vascular Stenting, Procedure Volumes Forecast, 2009-2014 
Exhibit 3-2: Peripheral Vascular Stenting Systems, Market Forecast, 2009-2014 
Exhibit 3-3: 2010, Selected Current and Emerging Endovascular Aortic Aneurysm Repair Systems 
Exhibit 3-4: Aortic Aneurysm Stent-Grafts, Market Forecast, 2009-2014 
Exhibit 3-5: 2009, Abdominal Aortic Aneurysm Stent-Grafts Market,  Share by Supplier 
Exhibit 3-6: 2009, Thoracic Aortic Aneurysm Stent-Grafts Market,  Share by Supplier 
Exhibit 3-7: 2009, Combined Aortic Aneurysm Stent-Grafts Market,  Share by Supplier 
Exhibit 3-8: 2010, Selected Current and Emerging Carotid Artery Stenting and Embolic Protection Systems 
Exhibit 3-9: Distally Protected Carotid Artery Stenting Systems, Market Forecast, 2009-2014 
Exhibit 3-10: 2009, Distally Protected Carotid Artery Stenting Systems Market, Share by Supplier 
Exhibit 3-11: 2010, Selected Current and Emerging Lower Extremity Stenting Systems 
Exhibit 3-12: Lower Extremity Stenting Systems, Market Forecast, 2009-2014 
Exhibit 3-13: 2009, Iliac Stents Market, Share by Supplier 
Exhibit 3-14: 2009, Femoropopliteal Stents Market, Share by Supplier 
Exhibit 3-15: 2010, Selected Current and Emerging Renal Artery Stenting Systems 
Exhibit 3-16: Renal Artery Stenting Systems, Market Forecast, 2009-2014 
Exhibit 3-17: 2009, Renal Artery Stenting Systems Market, Share by Supplier 
Exhibit 3-18: 2010, Selected Transjugular Intrahepatic Portosystemic Shunt Systems 
Exhibit 3-19: Transjugular Intrahepatic Portosystemic Shunt Systems, Market Forecast, 2009-2014 
Exhibit 3-20: 2009, Transjugular Intrahepatic Portosystemic Shunt  Systems Market, Share by Supplier 

4. COMPANY PROFILES

4.1 Abbott Laboratories 
4.2 Boston Scientific Corporation 
4.3 Cook Group, Inc.
4.4 Cordis Corporation/Johnson & Johnson 
4.5 ev3, Inc./Covidien, Inc. 
4.6 Medtronic, Inc. 
4.7 W.L. Gore & Associates, Inc. 

APPENDIX:  COMPANY LISTING 


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Boston Scientific Corporation
  3. Cook Group, Inc.
  4. Cordis Corporation/Johnson & Johnson
  5. ev3, Inc./Covidien, Inc.
  6. Medtronic, Inc.
  7. W.L. Gore & Associates, Inc.
Contact Us

Need help finding medtech research? Let us help you!